Stent Retrievers Clinical Pipeline Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Stent Retrievers Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to's offering.

Stent Retrievers Pipeline Report' provides comprehensive information about the Stent Retrievers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Stent retrievers are deployed by a catheter that is threaded through the clot.


  • Extensive coverage of the Stent Retrievers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Stent Retrievers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Stent Retrievers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Stent Retrievers Overview

3 Products under Development
3.1 Stent Retrievers - Pipeline Products by Stage of Development
3.2 Stent Retrievers - Pipeline Products by Territory
3.3 Stent Retrievers - Pipeline Products by Regulatory Path
3.4 Stent Retrievers - Pipeline Products by Estimated Approval Date
3.5 Stent Retrievers - Ongoing Clinical Trials

4 Stent Retrievers - Pipeline Products under Development by Companies
4.1 Stent Retrievers Companies - Pipeline Products by Stage of Development
4.2 Stent Retrievers - Pipeline Products by Stage of Development

5 Stent Retrievers Companies and Product Overview

6 Stent Retrievers- Recent Developments
6.1 Jun 06, 2023: Zylox-tonbridge Medical Technology Co. Announces Poll Results of the 2022 Annual General Meeting
6.2 Mar 30, 2023: Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million
6.3 Sep 15, 2022: Zylox-Tonbridge Medical Technology Co Ltd announced interim report for 2022

7 Appendix

A selection of companies mentioned in this report includes

  • Amnis Therapeutics Ltd
  • Biomedical Solutions Inc
  • Capital Medical University
  • HeMo Bioengineering Ltd
  • Insera Therapeutics LLC
  • Medtronic Plc
  • MicroPort NeuroTech Ltd
  • MiVi Neuroscience LLC
  • Nanjing Kanite Medical Technology Co Ltd
  • NeuroVasc Technologies Inc
  • OrbusNeich
  • Perflow Medical, Ltd.
  • Rapid Medical
  • Shanghai HeartCare Medical Technology Co Ltd
  • Shanghai MicroPort Medical Group Co Ltd
  • SinoMedCare Biotech Co Ltd
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Triticum Medical Ltd.
  • Vesalio LLC
  • Zhejiang Kindly Medical Devices Co Ltd
  • Zylox-Tonbridge Medical Technology Co Ltd

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data